Chairman Wang Wenjie is from Hubei.

Wang Wenjie, male, born in August 1969, Chinese nationality, no permanent residence abroad, college degree. Currently, he is the legal representative and chairman of Beijing Changfeng Hospital Co., Ltd. (Changfeng Hospital). He once served as a director of the China Non-Public Medical Institutions Association and the chairman of the Hemangioma and Vascular Malformation Professional Committee. From June 1992 to June 2001, he worked clinically in Ezhou Traditional Chinese Medicine Hospital. From June 2001 to May 2006, he served as the president of Ezhou Traditional Chinese Medicine Hemangioma Hospital from May 2006 to November 2009.

Served as the president of Fengtai Changfeng Hospital in Beijing. From December 2009 to January 2016, he served as executive director and manager of Changfeng Hospital Co., Ltd.; from January 2016 to January 2019, he served as chairman and general manager of Beijing Changfeng Hospital Co., Ltd. Currently, he is the legal representative and chairman of Beijing Changfeng Hospital Co., Ltd. (Changfeng Hospital).

Introduction to Wang Wenjie’s personal life:

Wang Wenjie was born in a family of doctors in August 1969. His father was a well-known local hemangioma doctor. Because he was influenced by his father's life-saving work since childhood, he applied for medical school when he grew up, determined to become a doctor. After graduating from Hunan Yueyang College of Traditional Chinese Medicine, Wang Wenjie was not content to be an ordinary doctor even though he only had a college degree.

In 1997, 26-year-old Wang Wenjie developed a pure traditional Chinese medicine preparation "Hua Tuo No. 1, No. 2, and No. 3; Blood Tumor Cream No. 1, No. 2, and No. 3; Blood Tumor Cream No. Leukang No. 1 and No. 2." This invention was awarded the "Huatuo Cup" gold medal by the International Association of Traditional Medicine, and was approved by the Hubei Provincial Food and Drug Administration as a pure traditional Chinese medicine preparation and used in clinical applications.

Subsequently, Wang Wenjie invented a new method of minimally invasive high-frequency electrocoagulation for the treatment of hemangioma and vascular malformation, overcoming the medical problems of hemangioma, and was introduced as a special talent by the Ezhou Municipal Government of Hubei Province. He is the deputy chief physician and associate physician.